Lyell Immunopharma (LYEL) Net Margin (2020 - 2025)
Historic Net Margin for Lyell Immunopharma (LYEL) over the last 6 years, with Q3 2025 value amounting to 226580.0%.
- Lyell Immunopharma's Net Margin fell 955800000.0% to 226580.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 798982.93%, marking a year-over-year decrease of 4959924500.0%. This contributed to the annual value of 548667.21% for FY2024, which is 3767018300.0% down from last year.
- As of Q3 2025, Lyell Immunopharma's Net Margin stood at 226580.0%, which was down 955800000.0% from 548300.0% recorded in Q2 2025.
- In the past 5 years, Lyell Immunopharma's Net Margin ranged from a high of 23.42% in Q4 2022 and a low of 2139533.33% during Q3 2022
- For the 5-year period, Lyell Immunopharma's Net Margin averaged around 448089.51%, with its median value being 209724.0% (2023).
- In the last 5 years, Lyell Immunopharma's Net Margin crashed by 2000000000bps in 2022 and then surged by 2000000000bps in 2023.
- Over the past 5 years, Lyell Immunopharma's Net Margin (Quarter) stood at 1673.1% in 2021, then surged by 99bps to 23.42% in 2022, then plummeted by -1721920bps to 403261.54% in 2023, then crashed by -342bps to 1783881.82% in 2024, then soared by 87bps to 226580.0% in 2025.
- Its Net Margin stands at 226580.0% for Q3 2025, versus 548300.0% for Q2 2025 and 764357.14% for Q1 2025.